Nonetheless, it is worth noting that COVID-19 patients exhibited lower levels of ApoA-I, ApoA-II, HDL-1, and HDL-3 cholesterol, which represent large- and medium-sized HDL particles. The gene discussed is APOA2; the disease is COVID-19.